{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:08:05Z","timestamp":1792674485484,"version":"4.5.0"},"reference-count":46,"publisher":"Pharmaceutical Society of Japan","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2020,1,1]]},"DOI":"10.1248\/bpb.b19-00616","type":"journal-article","created":{"date-parts":[[2019,12,31]],"date-time":"2019-12-31T22:08:49Z","timestamp":1577830129000},"page":"110-115","source":"Crossref","is-referenced-by-count":27,"title":["Neuroinflammation, Oxidative Stress, and Neurogenesis in a Mouse Model of Chronic Fatigue Syndrome, and the Treatment with Kampo Medicine"],"prefix":"10.1248","volume":"43","author":[{"given":"Qiang","family":"He","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mio","family":"Sawada","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naruhiro","family":"Yamasaki","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiyo","family":"Akazawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisakazu","family":"Furuta","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Uenishi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangjin","family":"Meng","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakahashi","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Ishigaki","sequence":"additional","affiliation":[{"name":"Division of Molecular and Cell Biology, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junji","family":"Moriya","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, Kanazawa Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. <i>Ann. Intern. Med.<\/i>, <b>121<\/b>, 953\u2013959 (1994)."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Komaroff AL. The biology of chronic fatigue syndrome. <i>Am. J. Med.<\/i>, <b>108<\/b>, 169\u2013171 (2000).","DOI":"10.1016\/S0002-9343(99)00282-X"},{"key":"3","unstructured":"3) Brurberg KG, Fonhus MS, Larun L, Flottorp S, Malterud K. Case definitions for chronic fatigue syndrome\/myalgic encephalomyelitis (CFS\/ME): a systematic review. <i>BMJ Open<\/i>, <b>4<\/b>, e003973 (2014)."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Devanur LD, Kerr JR. Chronic fatigue syndrome. <i>J. Clin. Virol.<\/i>, <b>37<\/b>, 139\u2013150 (2006).","DOI":"10.1016\/j.jcv.2006.08.013"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Clauw DJ. Perspectives on fatigue from the study of chronic fatigue syndrome and related conditions. <i>PM R<\/i>, <b>2<\/b>, 414\u2013430 (2010).","DOI":"10.1016\/j.pmrj.2010.04.010"},{"key":"6","unstructured":"6) Gimeno Pi I, Guitard Sein-Echaluce ML, Rossell\u00f3 Aubach L, Torres Puig-Gros J, Fern\u00e1ndez Sol\u00e0 J. Stressful Events in the Onset of Chronic Fatigue Syndrome. <i>Rev. Esp. Salud Publica<\/i>, <b>90<\/b>, e1\u2013e7 (2016)."},{"key":"7","unstructured":"7) Underhill RA. Myalgic encephalomyelitis, chronic fatigue syndrome: an infectious disease. <i>Med. Hypotheses<\/i>, <b>85<\/b>, 765\u2013773 (2015)."},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Morris G, Maes M. Oxidative and nitrosative stress and immune-inflammatory pathways in patients with Myalgic Encephalomyelitis (ME)\/Chronic Fatigue Syndrome (CFS). <i>Curr. Neuropharmacol.<\/i>, <b>12<\/b>, 168\u2013185 (2014).","DOI":"10.2174\/1570159X11666131120224653"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Cui H, Kong Y, Zhang H. Oxidative stress, mitochondrial dysfunction, and aging. <i>J. Signal Transduct.<\/i>, <b>2012<\/b>, 646354 (2012).","DOI":"10.1155\/2012\/646354"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Broderick G, Fuite J, Kreitz A, Vernon SD, Klimas N, Fletcher MA. A formal analysis of cytokine networks in chronic fatigue syndrome. <i>Brain Behav. Immun.<\/i>, <b>24<\/b>, 1209\u20131217 (2010).","DOI":"10.1016\/j.bbi.2010.04.012"},{"key":"11","unstructured":"11) Maes M, Twisk FN, Kubera M, Ringel K. Evidence for inflammation and activation of cell-mediated immunity in Myalgic Encephalomyelitis\/Chronic Fatigue Syndrome (ME\/CFS): increased interleukin-1, tumor necrosis factor-alpha, PMN-elastase, lysozyme and neopterin. <i>J. Affect. Disord.<\/i>, <b>136<\/b>, 933\u2013939 (2012)."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Morris G, Berk M, Galecki P, Walder K, Maes M. The neuro-immune pathophysiology of central and peripheral fatigue in systemic immune-inflammatory and neuro-immune diseases. <i>Mol. Neurobiol.<\/i>, <b>53<\/b>, 1195\u20131219 (2016).","DOI":"10.1007\/s12035-015-9090-9"},{"key":"13","unstructured":"13) Katafuchi T, Kondo T, Take S, Yoshimura M. Brain cytokines and the 5-HT system during poly I\u2009:\u2009C-induced fatigue. <i>Ann. N. Y. Acad. Sci.<\/i>, <b>1088<\/b>, 230\u2013237 (2006)."},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Konsman JP, Kelley K, Dantzer R. Temporal and spatial relationships between lipopolysaccharide-induced expression of Fos, interleukin-1beta and inducible nitric oxide synthase in rat brain. <i>Neuroscience<\/i>, <b>89<\/b>, 535\u2013548 (1999).","DOI":"10.1016\/S0306-4522(98)00368-6"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Pall ML. Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. <i>Med. Hypotheses<\/i>, <b>54<\/b>, 115\u2013125 (2000).","DOI":"10.1054\/mehy.1998.0825"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Monro JA, Puri BK. A molecular neurobiological approach to understanding the aetiology of chronic fatigue syndrome (myalgic encephalomyelitis or systemic exertion intolerance disease) with treatment implications. <i>Mol. Neurobiol.<\/i>, <b>55<\/b>, 7377\u20137388 (2018).","DOI":"10.1007\/s12035-018-0928-9"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Galecki P, Talarowska M, Anderson G, Berk M, Maes M. Mechanisms underlying neurocognitive dysfunctions in recurrent major depression. <i>Med. Sci. Monit.<\/i>, <b>21<\/b>, 1535\u20131547 (2015).","DOI":"10.12659\/MSM.893176"},{"key":"18","unstructured":"18) Catena-Dell\u2019Osso M, Bellantuono C, Consoli G, Baroni S, Rotella F, Marazziti D. Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development. <i>Curr. Med. Chem.<\/i>, <b>18<\/b>, 245\u2013255 (2011)."},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Kubera M, Obuchowicz E, Goehler L, Brzeszcz J, Maes M. In animal models, psychosocial stress-induced (neuro)inflammation, apoptosis and reduced neurogenesis are associated to the onset of depression. <i>Prog. Neuropsychopharmacol. Biol. Psychiatry<\/i>, <b>35<\/b>, 744\u2013759 (2011).","DOI":"10.1016\/j.pnpbp.2010.08.026"},{"key":"20","unstructured":"20) Tsumura &amp; Co. \u201cHochuekkito (TJ-41) extract granules.\u201d: \u2039https:\/\/www.tsumura.co.jp\/products\/pdf\/en\/041_otc.pdf\u203a, accessed 08 July, 2019."},{"key":"21","unstructured":"21) Tsumura &amp; Co. \u201cHachimijioganryo (TJ-7) extract granules.\u201d: \u2039https:\/\/www.tsumura.co.jp\/products\/pdf\/en\/007_otc.pdf\u203a, accessed 08 July, 2019."},{"key":"22","unstructured":"22) Harada M, Seta K, Ito O, Tamada K, Li T, Terao H, Takenoyama M, Kimura G, Nomoto K. Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang). <i>Immunopharmacol. Immunotoxicol.<\/i>, <b>17<\/b>, 687\u2013703 (1995)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Kuroiwa A, Liou S, Yan H, Eshita A, Naitoh S, Nagayama A. Effect of a traditional Japanese herbal medicine, hochu-ekki-to (Bu-Zhong-Yi-Qi Tang), on immunity in elderly persons. <i>Int. Immunopharmacol.<\/i>, <b>4<\/b>, 317\u2013324 (2004).","DOI":"10.1016\/j.intimp.2003.12.004"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Yae S, Takahashi F, Yae T, Yamaguchi T, Tsukada R, Koike K, Minakata K, Murakami A, Nurwidya F, Kato M, Tamada M, Yoshikawa M, Kobayashi H, Seyama K, Takahashi K. Hochuekkito (TJ-41), a Kampo formula, ameliorates cachexia induced by colon 26 adenocarcinoma in mice. <i>Evid. Based Complement. Alternat. Med.<\/i>, <b>2012<\/b>, 976926 (2012).","DOI":"10.1155\/2012\/976926"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Sekiya M, Kiyohara H, Maruyama H, Yabe T, Yamada H. Modulation of chemokine expression on intestinal epithelial cells by Kampo (traditional Japanese herbal) medicine, Hochuekkito, and its active ingredients. <i>J. Nat. Med.<\/i>, <b>67<\/b>, 626\u2013635 (2013).","DOI":"10.1007\/s11418-012-0724-1"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Matsumiya M, Kaibori M, Araki Y, Mastuura T, Oishi M, Tanaka Y, Nishizawa M, Okumura T, Kwon A. Japanese herbal medicine Hochuekkito inhibits the expression of proinflammatory biomarker, inducible nitric oxide synthase, in hepatocytes. <i>Med. Chem.<\/i>, <b>2<\/b>, 41\u201347 (2012).","DOI":"10.4172\/2161-0444.1000112"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Yamada K, Yagi G, Kanba S. Effectiveness of herbal medicine (Rokumigan and Hachimijiogan) for fatigue or loss of energy in patients with partial remitted major depressive disorder. <i>Psychiatry Clin. Neurosci.<\/i>, <b>59<\/b>, 610\u2013612 (2005).","DOI":"10.1111\/j.1440-1819.2005.01423.x"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Yamabe N, Yokozawa T. Protective effect of Hachimi-jio-gan against the development of pancreatic fibrosis and oxidative damage in Otsuka Long-Evans Tokushima Fatty rats. <i>J. Ethnopharmacol.<\/i>, <b>113<\/b>, 91\u201399 (2007).","DOI":"10.1016\/j.jep.2007.05.010"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Kim HY, Yokozawa T, Cho EJ, Yamabe N. Protective effects of the Chinese prescription Hachimi-jio-gan against diabetic oxidative stress. <i>J. Pharm. Pharmacol.<\/i>, <b>56<\/b>, 1299\u20131305 (2004).","DOI":"10.1211\/0022357044490"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Kubota K, Fukue H, Sato H, Hashimoto K, Fujikane A, Moriyama H, Watanabe T, Katsurabayashi S, Kainuma M, Iwasaki K. The traditional Japanese herbal medicine Hachimijiogan elicits neurite outgrowth effects in PC12 cells and improves cognitive in AD model rats <i>via<\/i> phosphorylation of CREB. <i>Front Pharmacol.<\/i>, <b>8<\/b>, 850 (2017).","DOI":"10.3389\/fphar.2017.00850"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Chen R, Moriya J, Yamakawa J, Takahashi T, Li Q, Morimoto S, Iwai K, Sumino H, Yamaguchi N, Kanda T. Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41). <i>Neurochem. Res.<\/i>, <b>33<\/b>, 1759\u20131767 (2008).","DOI":"10.1007\/s11064-008-9620-1"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Dan K, Akiyoshi H, Munakata K, Hasegawa H, Watanabe KA. Kampo (traditional Japanese herbal) medicine, Hochuekkito, pretreatment in mice prevented influenza virus replication accompanied with GM-CSF expression and increase in several defensin mRNA levels. <i>Pharmacology<\/i>, <b>91<\/b>, 314\u2013321 (2013).","DOI":"10.1159\/000350188"},{"key":"33","unstructured":"33) Horie H, Fujii Y, Katabami K, Iwama M, Yamada A. Suppressive effects of traditional herbal medicines on reversion of attenuated polio vaccine viruses to neurovirulent genotype. <i>J. Trad. Med.<\/i>, <b>24<\/b>, 156\u2013163 (2007)."},{"key":"34","unstructured":"34) Lucas K, Maes M. Role of the Toll like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway. <i>Mol. Neurobiol.<\/i>, <b>48<\/b>, 190\u2013204 (2013)."},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Kaminski M, Bechmann I, Pohland M, Kiwit J, Nitsch R, Glumm J. Migration of monocytes after intracerebral injection at entorhinal cortex lesion site. <i>J. Leukoc. Biol.<\/i>, <b>92<\/b>, 31\u201339 (2012).","DOI":"10.1189\/jlb.0511241"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Johnson JD, Cortez V, Kennedy SL, Foley TE, Hanson H 3rd, Fleshner M. Role of central beta-adrenergic receptors in regulating proinflammatory cytokine responses to a peripheral bacterial challenge. <i>Brain Behav. Immun.<\/i>, <b>22<\/b>, 1078\u20131086 (2008).","DOI":"10.1016\/j.bbi.2008.03.007"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Louveau A, Smirnov I, Keyes TJ, Eccles JD, Rouhani SJ, Peske JD, Derecki NC, Castle D, Mandell JW, Lee KS, Harris TH, Kipnis J. Structural and functional features of central nervous system lymphatic vessels. <i>Nature<\/i>, <b>523<\/b>, 337\u2013341 (2015).","DOI":"10.1038\/nature14432"},{"key":"38","unstructured":"38) Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, Onoe K, Fukuda S, Kawabe J, Takahashi K, Kataoka Y, Shiomi S, Yamaguti K, Inaba M, Kuratsune H, Watanabe Y. Neuroinflammation in patients with chronic fatigue syndrome\/myalgic encephalomyelitis: an <sup>11<\/sup>C-(R)-PK11195 PET study. <i>J. Nucl. Med.<\/i>, <b>55<\/b>, 945\u2013950 (2014)."},{"key":"39","unstructured":"39) Barnden LR, Crouch B, Kwiatek R, Burnet R, Mernone A, Chryssidis S, Scroop G, Del Fante P. A brain MRI study of chronic fatigue syndrome: evidence of brainstem dysfunction and altered homeostasis. <i>NMR Biomed.<\/i>, <b>24<\/b>, 1302\u20131312 (2011)."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Balasubramaniam B, Carter DA, Mayer EJ, Dick AD. Microglia derived IL-6 suppresses neurosphere generation from adult human retinal cell suspensions. <i>Exp. Eye Res.<\/i>, <b>89<\/b>, 757\u2013766 (2009).","DOI":"10.1016\/j.exer.2009.06.019"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Liu B, Gao HM, Wang JY, Jeohn GH, Cooper CL, Hong JS. Role of nitric oxide in inflammation-mediated neurodegeneration. <i>Ann. N. Y. Acad. Sci.<\/i>, <b>962<\/b>, 318\u2013331 (2002).","DOI":"10.1111\/j.1749-6632.2002.tb04077.x"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. <i>Physiol. Rev.<\/i>, <b>87<\/b>, 315\u2013424 (2007).","DOI":"10.1152\/physrev.00029.2006"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Bartesaghi S, Radi R. Fundamentals on the biochemistry of peroxynitrite and protein tyrosine nitration. <i>Redox Biol.<\/i>, <b>14<\/b>, 618\u2013625 (2018).","DOI":"10.1016\/j.redox.2017.09.009"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Schoenfeld TJ, Cameron HA. Adult neurogenesis and mental illness. <i>Neuropsychopharmacology<\/i>, <b>40<\/b>, 113\u2013128 (2015).","DOI":"10.1038\/npp.2014.230"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Karege F, Vaudan G, Schwald M, Perroud N, La Harpe R. Neurotrophin levels in postmortem brains of suicide victims and the effects of antemortem diagnosis and psychotropic drugs. <i>Brain Res. Mol. Brain Res.<\/i>, <b>136<\/b>, 29\u201337 (2005).","DOI":"10.1016\/j.molbrainres.2004.12.020"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Lu J, Xu Y, Hu W, Gao Y, Ni X, Sheng H, Liu Y. Exercise ameliorates depression-like behavior and increases hippocampal BDNF level in ovariectomized rats. <i>Neurosci. Lett.<\/i>, <b>573<\/b>, 13\u201318 (2014).","DOI":"10.1016\/j.neulet.2014.04.053"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/1\/43_b19-00616\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T05:14:36Z","timestamp":1578287676000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/43\/1\/43_b19-00616\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b19-00616","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,1]]}}}